Clinical experience with 6-month subcutaneous leuprolide acetate for central precocious puberty

被引：0
|
作者：
Matushek, Jori [1 ]
Boldt-Houle, Deborah M. [2 ]
Atkinson, Stuart N. [2 ]
机构：
[1] Peyton Manning Childrens Hosp St Vincent, Pediat Endocrinol & Diabet, Indianapolis, IN USA
[2] Tolmar Pharmaceut Inc, Med Affairs, Buffalo Grove, IL USA
来源：
JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES | 2023年 / 72卷
关键词：
D O I：
10.1016/j.pedn.2023.06.042
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
12
引用
收藏
页码：202 / 203
页数：2
相关论文
共 50 条
  • [31] Efficacy and Safety of Leuprolide Acetate 3 Month Depot 11.25 or 30 mg for the Treatment of Central Precocious Puberty.
    Lee, P. A.
    Klein, K.
    Mauras, N.
    Yang, D.
    Mattia-Goldberg, C.
    Chwalisz, K.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [32] EFFECTS OF LEUPROLIDE IN THE TREATMENT OF CENTRAL PRECOCIOUS PUBERTY
    LEE, PA
    PAGE, JG
    JOURNAL OF PEDIATRICS, 1989, 114 (02): : 321 - 324
  • [33] Pharmacokinetic and Exposure-Response Analyses of Leuprolide Following Administration of Leuprolide Acetate 3-Month Depot Formulations to Children with Central Precocious Puberty
    Mostafa, Nael M.
    Hosmane, Balakrishna
    Larsen, Lois M.
    Chwalisz, Kristof
    Chiu, Yi-Lin
    Pradhan, Rajendra S.
    CLINICAL DRUG INVESTIGATION, 2014, 34 (07) : 441 - 448
  • [34] Comparison of three doses of leuprolide acetate in the treatment of central precocious puberty: preliminary results
    Mericq, Veronica
    Javier Lammoglia, Juan
    Unanue, Nancy
    Villaroel, Claudio
    Isabel Hernandez, Maria
    Avila, Alejandra
    Iniguez, German
    Klein, Karen Oerter
    CLINICAL ENDOCRINOLOGY, 2009, 71 (05) : 686 - 690
  • [35] 2-YEAR RESULTS OF TREATMENT WITH DEPOT LEUPROLIDE ACETATE FOR CENTRAL PRECOCIOUS PUBERTY
    NEELY, EK
    HINTZ, RL
    PARKER, B
    BACHRACH, LK
    COHEN, P
    OLNEY, R
    WILSON, DM
    JOURNAL OF PEDIATRICS, 1992, 121 (04): : 634 - 640
  • [36] Efficacy and Safety of Leuprolide Acetate 3-Month Depot 11.25 Milligrams or 30 Milligrams for the Treatment of Central Precocious Puberty
    Lee, Peter A.
    Klein, Karen
    Mauras, Nelly
    Neely, E. Kirk
    Bloch, Clifford A.
    Larsen, Lois
    Mattia-Goldberg, Cynthia
    Chwalisz, Kristof
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (05): : 1572 - 1580
  • [37] Comparison of depot leuprolide doses in central precocious puberty
    Badaru, A
    Wilson, DM
    Neely, EK
    PEDIATRIC RESEARCH, 2004, 55 (04) : 155A - 155A
  • [38] Comparison of depot leuprolide doses in central precocious puberty
    Badaru, A
    Wilson, D
    Neely, EK
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152
  • [39] Leuprolide and fracture risk in patients with central precocious puberty
    Qiang, Yandong
    Menzin, Talia
    Hampp, Christian
    Lee, Hye Seung
    Sullivian, Shannon
    Zhao, Yueqin
    Huang, Ting-Ying
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 277 - 277
  • [40] Changes of thyroid function in girls with central precocious puberty after 6-month GnRH agonist treatment
    Huh, Rimm
    Chung, Lindsey Yoojin
    Nam, Hyo-Kyoung
    Rhie, Young-Jun
    Lee, Kee-Hyoung
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 492 - 493
12345